North Rock Partners, LLC Bio Techne Corp Transaction History

North Rock Partners, LLC

$1.16 Billion
Q2 2024

A detailed history of North Rock Partners, LLC transactions in Bio Techne Corp stock. As of the latest transaction made, North Rock Partners, LLC holds 8,127 shares of TECH stock, worth $649,428. This represents 0.05% of its overall portfolio holdings.

Number of Shares

8,127

Previous 7,862 3.37%

Holding current value

$649,428

Previous $553,000 5.24%

% of portfolio

0.05%

Previous 0.05%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$62.12 - $84.15 $16,461 - $22,299	265 Added 3.37%	8,127 $582,000
Q1 2024 May 07, 2024	BUY	$65.98 - $77.09 $212,323 - $248,075	3,218 Added 69.29%	7,862 $553,000
Q4 2023 Feb 08, 2024	BUY	$52.83 - $78.22 $58,165 - $86,120	1,101 Added 31.08%	4,644 $358,000
Q3 2023 Oct 24, 2023	SELL	$67.52 - $89.42 $45,035 - $59,643	-667 Reduced 15.84%	3,543 $241,000
Q2 2023 Aug 02, 2023	SELL	$73.76 - $85.98 $13,055 - $15,218	-177 Reduced 4.03%	4,210 $343,000
Q1 2023 May 03, 2023	BUY	$71.62 - $86.62 $5,872 - $7,102	82 Added 1.9%	4,387 $325,000
Q4 2022 Feb 01, 2023	BUY	$80.67 - $352.29 $277,343 - $1.21 Million	3,438 Added 396.54%	4,305 $356,000
Q3 2022 Nov 02, 2022	BUY	$282.54 - $391.85 $5,368 - $7,445	19 Added 2.24%	867 $246,000
Q2 2022 Aug 04, 2022	SELL	$322.67 - $449.65 $63,243 - $88,131	-196 Reduced 18.77%	848 $294,000
Q1 2022 May 05, 2022	BUY	$353.85 - $487.79 $77,493 - $106,826	219 Added 26.55%	1,044 $452,000
Q4 2021 Feb 07, 2022	BUY	$456.15 - $525.06 $376,323 - $433,174	825 New	825 $427,000

Others Institutions Holding TECH

# of Institutions

604

Shares Held

153M

Call Options Held

171K

Put Options Held

56.9K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $3.13B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of North Rock Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on North Rock Partners, LLC with notifications on news.

Account

North Rock Partners, LLC Bio Techne Corp Transaction History